PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 178 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $2,038,000 | -50.9% | 60,416 | -22.9% | 0.20% | -63.0% |
Q1 2016 | $4,152,000 | +0.1% | 78,360 | +45.0% | 0.55% | +25.8% |
Q4 2015 | $4,149,000 | +137.9% | 54,024 | +27.3% | 0.43% | +130.9% |
Q3 2015 | $1,744,000 | -38.4% | 42,436 | +6.0% | 0.19% | -34.5% |
Q2 2015 | $2,832,000 | -9.1% | 40,041 | +14.2% | 0.29% | -8.3% |
Q1 2015 | $3,115,000 | +2.0% | 35,062 | +1.8% | 0.31% | +1.6% |
Q4 2014 | $3,055,000 | +6.9% | 34,452 | +16.8% | 0.31% | +3.7% |
Q3 2014 | $2,859,000 | +5.5% | 29,502 | 0.0% | 0.30% | +16.0% |
Q2 2014 | $2,710,000 | +30.3% | 29,502 | -0.7% | 0.26% | +22.5% |
Q1 2014 | $2,080,000 | – | 29,718 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 2,799,916 | $121,768,000 | 8.62% |
Tamarack Advisers, LP | 625,000 | $27,044,000 | 8.22% |
NEXTHERA CAPITAL LP | 149,086 | $6,484,000 | 5.40% |
Spyglass Capital Management LLC | 379,609 | $16,509,000 | 5.22% |
Gagnon Advisors, LLC | 107,412 | $4,671,000 | 2.67% |
GAGNON SECURITIES LLC | 278,613 | $12,117,000 | 2.61% |
Asymmetry Capital Management, L.P. | 84,735 | $3,685,000 | 2.00% |
Rock Springs Capital Management LP | 1,250,000 | $54,363,000 | 1.97% |
Lisanti Capital Growth, LLC | 118,620 | $5,159,000 | 1.68% |
Elk Creek Partners, LLC | 500,069 | $21,748,000 | 1.62% |